Halladay Benjamin sold ESPR
December 17, 2025 · Form 4 insider transaction
Halladay Benjamin sold 7,337 shares of Esperion Therapeutics, Inc. Common Stock at $3.67 per share, a transaction worth $26.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
7,337
Price
$3.67
Total value
$26.9K
InsiderHalladay Benjamin
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 17, 2025
Filing dateDecember 18, 2025
Shares owned after467,525
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold to satisfy tax obligation on vested shares of restricted stock units.